Accelerate to discover
Related topics
Immunophenotyping Extracellular Vesicles using Amnis CellStream
May 29, 2020
Attempts to analyze EVs using traditional PMT- based flow cytometers has been hampered by the limit of detection of...
Four-week individual caging of male ICR mice alters body composition without change in body mass
May 25, 2020
Could individual caging affect the physical composition of outbred mice? To investigate this, dual X-ray absorptiometry...
Detect structural variants at 1% allele fraction: Dive deeper into heterogeneous cancer samples
May 22, 2020
To get a complete picture of highly rearranged cancer genomes in heterogeneous samples, use Bionano genome imaging...
Insulin receptor substrate 1 is a substrate of the Pim protein kinases
May 18, 2020
The goal of these studies was to identify Pim substrate(s) that could help define the pathway regulated by these...
Introducing Tonbo Biosciences flow cytometry reagents & antibodies
May 7, 2020
Tonbo Biosciences flow cytometry reagents & antibodies are manufactured with the highest quality and precision and...
Implementation of Micro CT in CAD/CAM dentistry for image processing and soft computing
May 4, 2020
Present radiology devices are playing an important role in clinical dentistry but their area of application islimited...
Introducing MDx platform: the fastest COVID-19 technology
Apr 20, 2020
BJS Biotechnologie introduces the Fast COVID-19™ test platform, a rapid sample-to-results test system for COVID-19. The...
Monitoring Lung tumor using Bioluminescence, Fluorescence and microCT
Apr 14, 2020
Preclinical in vivo imaging have complementary relative strengths in sensitivity, resolution and molecular versus...
May 18, 2016
With the increasing need for new therapies for cancer, autoimmune disorders and Alzheimer’s disease, monoclonal antibodies are proving very successful due to their high affinity and specificity for their target antigens. In cancer, for example, their first use was as antagonists of oncogenic receptor tyrosine kinases, but today monoclonal antibodies have emerged as vehicles for the targeted delivery of potent chemotherapeutic agents and as powerful tools to manipulate anticancer immune responses. Currently,
more than 30 antibody therapeutics are marketed worldwide. Some analysts predict that, given the rate of current revenue growth and potential new approvals, the global market could reach $58 billion by 2016. In addition, there are hundreds of monoclonal antibody-based biologic drugs in various phases of clinical trials worldwide.
Get more info
Brand profile
IntelliCyt Corporation's high throughput flow technology is the first to enable screening suspension cells, beads, microbes and mixtures.
More info at:
www.intellicyt.com/
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
